Lincoln Pharmaceuticals Ltd approves preferential issue at Rs. 82

The Board of Directors of Lincoln Pharmaceuticals Ltd at its meeting held on April 16, 2015, has subject to the approval of the shareholders of the Company at the Extra Ordinary General Meeting to be held on May 15, 2015 and stock exchanges where the shares of the Company are listed, considered and approved, issue of 36,89,200 convertible warrants on preferential basis at price of Rs. 82/- per warrant to the promoters / promoters' group and persons other than the promoters.

Shri Mahendra G. Patel, Managing Director of the Company has been authorized to take appropriate actions in the said matter.

Shares of LINCOLN PHARMACEUTICALS LTD. was last trading in BSE at Rs.89.75 as compared to the previous close of Rs. 91.25. The total number of shares traded during the day was 575759 in over 6459 trades.

The stock hit an intraday high of Rs. 95 and intraday low of 87.5. The net turnover during the day was Rs. 52783842.

Source : Equity Bulls

Keywords